GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 97 filers reported holding GOSSAMER BIO INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,657,932 | -84.6% | 9,195,404 | +121.0% | 0.26% | -82.5% |
Q3 2022 | $49,847,000 | +1652.1% | 4,160,887 | +1314.2% | 1.47% | +861.4% |
Q4 2020 | $2,845,000 | -78.8% | 294,221 | -63.2% | 0.15% | -91.0% |
Q3 2019 | $13,432,000 | -21.6% | 800,000 | +3.6% | 1.70% | -2.0% |
Q2 2019 | $17,125,000 | +2.4% | 772,096 | 0.0% | 1.73% | +12.2% |
Q1 2019 | $16,731,000 | – | 772,096 | – | 1.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 1,513,138 | $19,020,000 | 4.68% |
Omega Fund Management, LLC | 3,320,608 | $41,740,000 | 4.68% |
Ally Bridge Group (NY) LLC | 1,175,000 | $14,770,000 | 4.34% |
Parkman Healthcare Partners LLC | 786,870 | $9,891,000 | 2.50% |
Palo Alto Investors LP | 1,772,950 | $22,286,000 | 1.34% |
HHLR ADVISORS, LTD. | 7,420,974 | $93,282,000 | 1.22% |
Ikarian Capital, LLC | 1,351,933 | $16,995,000 | 1.20% |
Boxer Capital, LLC | 2,462,358 | $30,952,000 | 1.08% |
ACUTA CAPITAL PARTNERS, LLC | 215,000 | $2,703,000 | 0.95% |
EMERALD ADVISERS, LLC | 1,516,003 | $19,056,000 | 0.69% |